Evaluating the Effectiveness of an Additional Risk...

Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries

Heintjes, Edith, Bezemer, Irene D, Prieto-Alhambra, Daniel, Smits, Elisabeth, Booth, Helen P, Dedman, Daniel, He, Ying, Hoti, Fabian, Vehkala, Minna, de Vogel, Stefan, Robinson, Noah Jamie, Appenteng,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
Volume 12
Journal:
Clinical Epidemiology
DOI:
10.2147/CLEP.S242065
Date:
May, 2020
File:
PDF, 3.03 MB
2020
Conversion to is in progress
Conversion to is failed